To learn more, please call our Research Department at (513) 751-2273 or email
mhoelle@ohcare.com
| Metastatic, first-line |
| Study number: |
GI 152 Eli Lilly I4T-MC-JVBT |
| Protocol title: |
Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product (IMC-1121B) versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Stomach |
| Status |
Open
|